Pharma Aids Limited has recommended 50 percent cash dividend for the shareholders for the year ended on June 30, 2022.
The dividend payout was recommended at the company’s board of directors meeting, said the company in a filing with the Dhaka Stock Exchange (DSE) on Thursday.
However, final approval regarding the dividend will come during the Annual General Meeting (AGM) scheduled for December 27, 2022, to be held on digital platform.
The company has reported EPS of Tk 11.14 and consolidated NAV per share of Tk 98.83 during the period.
The record date for the distribution of the declared dividend among the shareholders has been fixed as December 8, 2022.
The company has also reported that EPS significantly decreased mostly due to deferred tax expense and deferred tax liability, provision for bad debt expenses, changes in accounting estimates with respect to provision for gratuity and write-off of an unsettled VAT Case that was shown as an asset in prior years.
